Charles Y. Lin

16.9k total citations · 5 hit papers
64 papers, 8.7k citations indexed

About

Charles Y. Lin is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Charles Y. Lin has authored 64 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 16 papers in Hematology and 13 papers in Oncology. Recurrent topics in Charles Y. Lin's work include Protein Degradation and Inhibitors (22 papers), Multiple Myeloma Research and Treatments (9 papers) and Genomics and Chromatin Dynamics (9 papers). Charles Y. Lin is often cited by papers focused on Protein Degradation and Inhibitors (22 papers), Multiple Myeloma Research and Treatments (9 papers) and Genomics and Chromatin Dynamics (9 papers). Charles Y. Lin collaborates with scholars based in United States, China and United Kingdom. Charles Y. Lin's co-authors include Peter B. Rahl, Richard A. Young, Brian J. Abraham, Denes Hnisz, David A. Orlando, Warren A. Whyte, Richard A. Young, Michael H. Kagey, James E. Bradner and Tong Ihn Lee and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Charles Y. Lin

62 papers receiving 8.6k citations

Hit Papers

Master Transcription Factors and Mediator Establish Super... 2010 2026 2015 2020 2013 2012 2010 2013 2014 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
    2013 2.7k citations Denes Hnisz, Brian J. Abraham et al. Cell profile →
  2. Transcriptional Amplification in Tumor Cells with Elevated c-Myc
    2012 1.1k citations Charles Y. Lin, Peter B. Rahl et al. Cell profile →
  3. c-Myc Regulates Transcriptional Pause Release
    2010 977 citations Peter B. Rahl, Charles Y. Lin et al. Cell profile →
  4. Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma
    2013 550 citations Bjoern Chapuy, Michael R. McKeown et al. Cancer Cell profile →
  5. NF-κB Directs Dynamic Super Enhancer Formation in Inflammation and Atherogenesis
    2014 453 citations Jonathan D. Brown, Charles Y. Lin et al. profile →

Peers

Charles Y. Lin
Peter B. Rahl United States
Henry Yang Singapore
Dirk Heckl Germany
Adrian P. Bracken Ireland
Kurtis E. Bachman United States
Brian J. Abraham United States
David O. Ferguson United States
Alexei Protopopov United States
Christopher R. Vakoc United States
Takehiko Kamijo Japan
Peter B. Rahl United States
Charles Y. Lin
Citations per year, relative to Charles Y. Lin Charles Y. Lin (= 1×) peers Peter B. Rahl

Countries citing papers authored by Charles Y. Lin

Since Specialization
Citations

This map shows the geographic impact of Charles Y. Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Y. Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Y. Lin more than expected).

Fields of papers citing papers by Charles Y. Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Y. Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Y. Lin. The network helps show where Charles Y. Lin may publish in the future.

Co-authorship network of co-authors of Charles Y. Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Y. Lin. A scholar is included among the top collaborators of Charles Y. Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Y. Lin. Charles Y. Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mita, Monica, Alain C. Mita, Miguel A. Villalona‐Calero, et al.. (2024). Abstract PO4-18-07: A dose escalation and cohort expansion study of the CDK9 inhibitor KB-0742 in triple negative breast cancer and transcriptionally addicted relapsed or refractory solid tumors. Cancer Research. 84(9_Supplement). PO4–18. 1 indexed citations
2.
Yao, Yao, Mehmet Samur, Eugenio Morelli, et al.. (2023). CDK7 controls E2F- and MYC-driven proliferative and metabolic vulnerabilities in multiple myeloma. Blood. 141(23). 2841–2852. 17 indexed citations
3.
4.
5.
Hsu, Austin, Qiming Duan, Daniel S. Day, et al.. (2022). Targeting transcription in heart failure via CDK7/12/13 inhibition. Nature Communications. 13(1). 4345–4345. 8 indexed citations
6.
Kalfon, Jérémie, Yaser Heshmati, Joshua M. Dempster, et al.. (2022). Transcriptional Plasticity Drives Leukemia Immune Escape. Blood Cancer Discovery. 3(5). 394–409. 12 indexed citations
7.
Jiang, Zhen, Qiming Duan, Edward L. LaGory, et al.. (2022). KLF15 cistromes reveal a hepatocyte pathway governing plasma corticosteroid transport and systemic inflammation. Science Advances. 8(10). eabj2917–eabj2917. 18 indexed citations
8.
9.
Dall’Agnese, Alessandra, Julien Dubrulle, Hannah L. Johnson, et al.. (2021). Targeted brachyury degradation disrupts a highly specific autoregulatory program controlling chordoma cell identity. Cell Reports Medicine. 2(1). 100188–100188. 20 indexed citations
10.
Horton, Terzah M., et al.. (2021). Defining the transcriptional control of pediatric AML highlights RARA as a superenhancer-regulated druggable dependency. Blood Advances. 5(23). 4864–4876. 5 indexed citations
11.
Giorgi, Marco De, Ang Li, Ayrea Hurley, et al.. (2021). Targeting the Apoa1 locus for liver-directed gene therapy. Molecular Therapy — Methods & Clinical Development. 21. 656–669. 14 indexed citations
12.
Stratton, Matthew S., Rushita A. Bagchi, Marina Barreto Felisbino, et al.. (2019). Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation. Circulation Research. 125(7). 662–677. 123 indexed citations
13.
Hu, Tianyuan, Xiangguo Shi, Ayumi Kitano, et al.. (2019). AMP-activated protein kinase links acetyl-CoA homeostasis to BRD4 recruitment in acute myeloid leukemia. Blood. 134(24). 2183–2194. 34 indexed citations
14.
Gaulis, Swann, Rui Lopes, Kathleen Sprouffske, et al.. (2019). PAX8 activates metabolic genes via enhancer elements in Renal Cell Carcinoma. Nature Communications. 10(1). 3739–3739. 43 indexed citations
15.
Zeid, Rhamy, Matthew A. Lawlor, Evon Poon, et al.. (2018). Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma. Nature Genetics. 50(4). 515–523. 129 indexed citations
16.
Brunetti, Lorenzo, Michael C. Gundry, Daniele Sorcini, et al.. (2018). Mutant NPM1 Maintains the Leukemic State through HOX Expression. Cancer Cell. 34(3). 499–512.e9. 195 indexed citations
17.
Saint‐André, Violaine, Alexander Federation, Charles Y. Lin, et al.. (2016). Models of human core transcriptional regulatory circuitries. Genome Research. 26(3). 385–396. 169 indexed citations
18.
Hnisz, Denes, Jurian Schuijers, Charles Y. Lin, et al.. (2015). Convergence of Developmental and Oncogenic Signaling Pathways at Transcriptional Super-Enhancers. DSpace@MIT (Massachusetts Institute of Technology). 139 indexed citations
19.
Chapuy, Bjoern, Michael R. McKeown, Charles Y. Lin, et al.. (2014). Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma. Cancer Cell. 25(4). 545–546. 13 indexed citations
20.
Xiong, Ji, Yu Zhou, Shatakshi Pandit, et al.. (2013). SR Proteins Collaborate with 7SK and Promoter-Associated Nascent RNA to Release Paused Polymerase. Cell. 153(4). 855–868. 260 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter B. Rahl Breakdown of academic impact, for papers by Henry Yang Breakdown of academic impact, for papers by Dirk Heckl Breakdown of academic impact, for papers by Adrian P. Bracken Breakdown of academic impact, for papers by Kurtis E. Bachman Breakdown of academic impact, for papers by Brian J. Abraham Breakdown of academic impact, for papers by David O. Ferguson Breakdown of academic impact, for papers by Alexei Protopopov Breakdown of academic impact, for papers by Christopher R. Vakoc Breakdown of academic impact, for papers by Takehiko Kamijo
Rankless by CCL
2026